US · Healthcare · Health Information Services
EPS came in at 0.45 against a street estimate of 0.37 — a beat of 21.6%.
Analysts rate BrightSpring Health Services, Inc. Common Stock a strong buy (11 buy, 1 hold, 0 sell out of 12) with an average price target of $78.53.
| Fund | Stake |
|---|---|
| Kohlberg Kravis Roberts & Co LP | 21.31% |
| FMR Inc | 10.69% |
| BlackRock Inc | 9.99% |
| Amvescap Plc. | 5.85% |
| T. Rowe Price Associates, Inc. | 5.44% |
| Vanguard Portfolio Management, LLC | 4.09% |
| T. Rowe Price Investment Management,Inc. | 3.89% |
| Vanguard Capital Management, LLC | 3.21% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 | 2026-07-31 |
| Results announced · Q3 2026 | 2026-07-31 |
| Board / officer change · Q2 2026 | 2026-06-12 |
| Material agreement · Q2 2026 | 2026-06-05 |
| Shareholder vote results · Q2 2026 | 2026-05-21 |
| Quarterly report · Q1 2026 | 2026-05-01 |
| Proxy statement · Q2 2026 | 2026-04-10 |
| Annual report FY2025 | 2026-02-27 |
Readable in the app.
| Announcement | Date |
|---|---|
| Q2 2026 results reported; full year 2026 revenue and EBITDA guidance increased BrightSpring Health Services reported strong second quarter 2026 results and raised full-year guidance. Key highlights: Revenue grew 23% to $3.87 billion, gross profit jumped 31.5% to $493 m | 2026-07-31 |
| Q1 2026 results reported, full year 2026 revenue and EBITDA guidance increased BrightSpring Health Services reported strong first-quarter 2026 results and raised full-year guidance. Key highlights: Revenue jumped 25.6% to $3.614 billion, gross profit surged 42.5% to $4 | 2026-05-01 |
| Full year 2026 revenue and adjusted EBITDA guidance initiated BrightSpring Health Services reported strong 2025 financial results with significant growth across key metrics. Revenue increased 28.2% to $12.9 billion, while Adjusted EBITDA grew 34.2% to | 2026-02-27 |
| Q3 2025 results reported; full year 2025 revenue guidance increased BrightSpring Health Services reported strong Q3 2025 results with revenues up 28.2% to $3.33 billion and swung from a $25.7 million net loss to a $37.5 million net income. Adjusted EBITDA gr | 2025-10-28 |
| Q3 2025 results and increased full year 2025 revenue and EBITDA guidance BrightSpring Health Services reported strong third quarter 2025 preliminary results and raised its full-year guidance. Key highlights: Q3 revenues reached $3.334 billion, up 28.2% year-over- | 2025-10-20 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for BrightSpring Health Services, Inc. Common Stock — free to start.
Google PlayApp StoreData updated 2026-08-05.